Society of Gynecologic Oncology
Tracked across 2 events · 14 articles · First seen May 06, 2025 · Last active Aug 06, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Tech
Impact: The Society of Gynecologic Oncology Annual Meeting is the venue where AbbVie presented the late-breaking Phase 2 data for Mirvetuximab soravtansine.
Apr 12, 2026 · 7 articles
Business
Impact: The society hosted a session where CORE-008 Cohort CX data were presented, contributing to the dissemination of clinical findings.
Aug 06, 2026 · 7 articles
ERGEN INTELLIGENCE
Track Society of Gynecologic Oncology live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard